Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
10,769
Total Claims
$1.1M
Drug Cost
832
Beneficiaries
$1,308
Cost/Patient
Risk Score Breakdown 15/100
Score components are additive. Read full methodology
Peer Comparison vs. 106,889 Family Practice providers
-5%
Opioid rate vs peers
2.5% vs 2.6% avg
+22%
Cost per patient vs peers
$1,308 vs $1,068 avg
+30%
Brand preference vs peers
11.7% vs 9.0% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
Opioid Prescribing
2.5%
Opioid Rate
264
Opioid Claims
$5,098
Opioid Cost
11.0%
Long-Acting Rate
Brand vs Generic
Brand: 1,245 claims · $874K
Generic: 9,429 claims · $203K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Empagliflozin | 71 | $89K |
| Apixaban | 58 | $80K |
| Mirabegron | 46 | $57K |
| Dulaglutide | 23 | $57K |
| Insulin Degludec | 35 | $48K |
| Semaglutide | 21 | $46K |
| Rivaroxaban | 24 | $38K |
| Dapagliflozin Propanediol | 14 | $24K |
| Fluticasone/Umeclidin/Vilanter | 14 | $22K |
| Budesonide/Formoterol Fumarate | 26 | $19K |
| Tirzepatide | 11 | $16K |
| Budesonide/Glycopyr/Formoterol | 15 | $15K |
| Insulin Glargine,hum.Rec.Anlog | 17 | $15K |
| Levothyroxine Sodium | 1,001 | $13K |
| Insulin Glargine/Lixisenatide | 11 | $9,620 |
Prescribing Profile
Patient Profile
74
Avg Age
70%
Female
0.97
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About